(Q50147449)

25 February 2018

title

Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges (English)

1 reference

25 February 2018

author name string

Deverka PA

series ordinal

1

1 reference

25 February 2018

Doksum T

series ordinal

2

1 reference

25 February 2018

Carlson RJ

series ordinal

3

1 reference

25 February 2018

language of work or name

English

0 references

publication date

8 August 2007

1 reference

25 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

25 February 2018

volume

82

1 reference

25 February 2018

issue

4

1 reference

25 February 2018

page(s)

427-434

1 reference

25 February 2018

Creating a new structure for research on health care effectiveness

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

The Sequence of the Human Genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Genomic medicine: genetic variation and its impact on the future of health care

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Genomic medicine: bringing biomarkers to clinical medicine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Prospective care: a personalized, preventative approach to medicine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Implications of the Human Genome Project for medical science.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Human genetics. Before it's too late--addressing fear of genetic information

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Evidence-based and value-based formulary guidelines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Measuring the value of pharmacogenomics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Creating incentives for genomic research to improve targeting of therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Developing a center for comparative effectiveness information

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Central Challenges Facing the National Clinical Research Enterprise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Linking pharmacogenetics-based diagnostics and drugs for personalized medicine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Defining the balance of risk and benefit in the era of genomics and proteomics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Coverage options for promising technologies: Medicare's 'coverage with evidence development'

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Translational research: moving discovery to practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

The Personalized Medicine Coalition: goals and strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100319

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100319

1 reference

25 February 2018

Dimensions Publication ID

1006211430

0 references

1 reference

25 February 2018